Study on the Protective Effect of Gastrodin on Myocardial Injury in Patients Undergoing Cardiac Surgery
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Degree of myocardial cell injury
研究概览
简要总结
This study intends to include hypertrophic cardiomyopathy patients over 18 years old who underwent cardiac surgery in our hospital. Patients were divided into medication group and control group according to the use of gastrodin during operation. The patients ' myocardial tissue samples were collected, the postoperative prognosis data were observed and recorded, and the data were analyzed. The degree of myocardial tissue cell damage and postoperative clinical outcomes were compared between the two groups.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with hypertrophic cardiomyopathy aged≥18 years, regardless of gender;
- •Patients undergoing elective hypertrophic cardiomyopathy outflow tract surgery;
- •Signed informed consent, good compliance.
排除标准
- •suffering from more serious genetic diseases (such as immunodeficiency, thalassemia, etc.);
- •moderate to severe malnutrition, moderate to severe anemia;
- •persistent infection;
- •severe preoperative underlying diseases (such as severe liver and kidney dysfunction)
结局指标
主要结局
Degree of myocardial cell injury
时间窗: During postoperative hospitalization stay, an average of about two weeks
Postoperative myocardial injury marker serum concentration, postoperative cardiac function ultrasound index
次要结局
未报告次要终点
